Closure of US site in Nutley, New Jersey expected to result in a reduction of around 1’000 positions. Respective R&D activities to be consolidated in Basel and Schlieren (Switzerland) and Penzberg (Germany).
...Roche Pharma will continue to have a presence on the US East Coast with a Pharmaceuticals Translational Clinical Research Center of about 240 positions.
...A location is being identified on the East Coast to focus on translational clinical research to support Roche US-based clinical trials and early development programs, support and maintain Roche interactions with the U.S. Food and Drug Administration (FDA), and enhance Roche’s collaborations with US based partners, such as academic institutions and biotech companies. This new center is expected to host around 240 employees.
...As a result of the closure of the Nutley site, Roche expects a reduction of around 1,000 positions on the US East Coast. The transferred activities can be largely absorbed by the existing sites in Switzerland and Germany with an increase of about 80 positions.
Roche is committed to handling the designated job reductions in a respectful manner and to finding socially responsible solutions for the employees affected. This includes informing employees who will be affected as soon as possible and providing appropriate plans and programs to support them during this transition process.
The new US East Coast Translational Research Clinical Center is planned to be operational by early 2013. The transfer of business operations in Nutley is planned to be completed by end of 2013.Call me naive, but I thought we were mostly done with the Big Pharma site closures. I guess not.
Best wishes to all affected.